157 related articles for article (PubMed ID: 38542507)
1. Exosomal Prostate-Specific Membrane Antigen (PSMA) and Caveolin-1 as Potential Biomarkers of Prostate Cancer-Evidence from Serbian Population.
Matijašević Joković S; Korać A; Kovačević S; Djordjević A; Filipović L; Dobrijević Z; Brkušanin M; Savić-Pavićević D; Vuković I; Popović M; Brajušković G
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542507
[TBL] [Abstract][Full Text] [Related]
2. Urine-derived exosomal PSMA is a promising diagnostic biomarker for the detection of prostate cancer on initial biopsy.
Wang CB; Chen SH; Zhao L; Jin X; Chen X; Ji J; Mo ZN; Wang FB
Clin Transl Oncol; 2023 Mar; 25(3):758-767. PubMed ID: 36266386
[TBL] [Abstract][Full Text] [Related]
3. MiR-375 and miR-21 as Potential Biomarkers of Prostate Cancer: Comparison of Matching Samples of Plasma and Exosomes.
Joković SM; Dobrijević Z; Kotarac N; Filipović L; Popović M; Korać A; Vuković I; Savić-Pavićević D; Brajušković G
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553586
[TBL] [Abstract][Full Text] [Related]
4. Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer.
Khan S; Jutzy JM; Valenzuela MM; Turay D; Aspe JR; Ashok A; Mirshahidi S; Mercola D; Lilly MB; Wall NR
PLoS One; 2012; 7(10):e46737. PubMed ID: 23091600
[TBL] [Abstract][Full Text] [Related]
5. Tumor-Derived Exosomal Long Noncoding RNAs as Promising Diagnostic Biomarkers for Prostate Cancer.
Wang YH; Ji J; Wang BC; Chen H; Yang ZH; Wang K; Luo CL; Zhang WW; Wang FB; Zhang XL
Cell Physiol Biochem; 2018; 46(2):532-545. PubMed ID: 29614511
[TBL] [Abstract][Full Text] [Related]
6. Semen miRNAs Contained in Exosomes as Non-Invasive Biomarkers for Prostate Cancer Diagnosis.
Barceló M; Castells M; Bassas L; Vigués F; Larriba S
Sci Rep; 2019 Sep; 9(1):13772. PubMed ID: 31551516
[TBL] [Abstract][Full Text] [Related]
7. Plasma extracellular vesicles as phenotypic biomarkers in prostate cancer patients.
Joncas FH; Lucien F; Rouleau M; Morin F; Leong HS; Pouliot F; Fradet Y; Gilbert C; Toren P
Prostate; 2019 Nov; 79(15):1767-1776. PubMed ID: 31475741
[TBL] [Abstract][Full Text] [Related]
8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
9. Prostate-specific extracellular vesicles as a novel biomarker in human prostate cancer.
Park YH; Shin HW; Jung AR; Kwon OS; Choi YJ; Park J; Lee JY
Sci Rep; 2016 Aug; 6():30386. PubMed ID: 27503267
[TBL] [Abstract][Full Text] [Related]
10. Nanoscale flow cytometry to distinguish subpopulations of prostate extracellular vesicles in patient plasma.
Padda RS; Deng FK; Brett SI; Biggs CN; Durfee PN; Brinker CJ; Williams KC; Leong HS
Prostate; 2019 May; 79(6):592-603. PubMed ID: 30680751
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Efficacy of PSMA and PSCA mRNAs Combined to PSA in Prostate Cancer Patients.
Mahmoud MM; Abdel Hamid FF; Abdelgawad I; Ismail A; Malash I; Ibrahim DM
Asian Pac J Cancer Prev; 2023 Jan; 24(1):223-229. PubMed ID: 36708571
[TBL] [Abstract][Full Text] [Related]
12. Functional prostate-specific membrane antigen is enriched in exosomes from prostate cancer cells.
Liu T; Mendes DE; Berkman CE
Int J Oncol; 2014 Mar; 44(3):918-22. PubMed ID: 24424840
[TBL] [Abstract][Full Text] [Related]
13. High expression of PSM-E correlated with tumor grade in prostate cancer: a new alternatively spliced variant of prostate-specific membrane antigen.
Cao KY; Mao XP; Wang DH; Xu L; Yuan GQ; Dai SQ; Zheng BJ; Qiu SP
Prostate; 2007 Dec; 67(16):1791-800. PubMed ID: 17929272
[TBL] [Abstract][Full Text] [Related]
14. Alterations of plasma exosomal proteins and motabolies are associated with the progression of castration-resistant prostate cancer.
Liu P; Wang W; Wang F; Fan J; Guo J; Wu T; Lu D; Zhou Q; Liu Z; Wang Y; Shang Z; Chan FL; Yang W; Li X; Zhao SC; Zheng Q; Wang F; Wu D
J Transl Med; 2023 Jan; 21(1):40. PubMed ID: 36681849
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of epithelial/stromal caveolin-1 expression in prostatic hyperplasia, high grade prostatic intraepithelial hyperplasia and prostatic carcinoma and its correlation with microvessel density.
Mohammed DA; Helal DS
J Egypt Natl Canc Inst; 2017 Mar; 29(1):25-31. PubMed ID: 28259631
[TBL] [Abstract][Full Text] [Related]
16. Gamma-glutamyltransferase activity in exosomes as a potential marker for prostate cancer.
Kawakami K; Fujita Y; Matsuda Y; Arai T; Horie K; Kameyama K; Kato T; Masunaga K; Kasuya Y; Tanaka M; Mizutani K; Deguchi T; Ito M
BMC Cancer; 2017 May; 17(1):316. PubMed ID: 28476099
[TBL] [Abstract][Full Text] [Related]
17. Exosomal microRNA-141 is upregulated in the serum of prostate cancer patients.
Li Z; Ma YY; Wang J; Zeng XF; Li R; Kang W; Hao XK
Onco Targets Ther; 2016; 9():139-48. PubMed ID: 26770063
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Vitronectin Expression in Prostate Cancer and the Clinical Significance of the Association of Vitronectin Expression with Prostate Specific Antigen in Detecting Prostate Cancer.
Niu Y; Zhang L; Bi X; Yuan S; Chen P
Urol J; 2016 Mar; 13(1):2527-32. PubMed ID: 26945657
[TBL] [Abstract][Full Text] [Related]
19. Is prostate volume better than PSA density and free/total PSA ratio in predicting prostate cancer in patients with PSA 2.5-10 ng/mL and 10.1-30 ng/mL?
Erdogan A; Polat S; Keskin E; Turan A
Aging Male; 2020 Mar; 23(1):59-65. PubMed ID: 30862227
[No Abstract] [Full Text] [Related]
20. [Early diagnosis of prostate cancer by combined use of Trp-p8 expression and PSA density of the transition zone].
Zhang XS; Zhang Y; Wu PX; Liu SJ; Zhou JY; Liu SX
Zhonghua Nan Ke Xue; 2015 Aug; 21(8):724-8. PubMed ID: 26442301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
